On November 30, 2011 Ranbaxy Laboratories launched the generic equivalent for Lipitor, atorvastatin. Ranbaxy will be the sole manufacturer of this generic drug for the next 180 days. Other manufacturers of the drug will be available in May 2012.
The savings at the beginning will be minimal, but once May 2012 roles around we should see substantial savings. This means big savings to consumers and payers alike.